Skip to main content

Table 4 Two-way ANOVA with tests of between-subjects effects for all variables tested, estimated marginal means and pairwise comparison for the IOP dependent variable and intergroup t-test comparison between Preserflo Microshunt with MMC 0.2 mg/ml and Preserflo Microshunt with MMC 0.2 mg/ml and Ologen implantation

From: Preliminary results of Preserflo Microshunt versus Preserflo Microshunt and Ologen implantation

Two-way ANOVA

Levene’s test for equality of error variances

F

DF 1

DF 2

P

3.9319

11

271

< 0.001

Tests of between-subjects effects (all variables)

Source

Sum of squares

DF

Mean square

F

Partial eta squared

Observed powerb

P

Follow up

9514.47

5

1902.89

98.70

0.639

1.0

< 0.001

Intervention

36.31

1

36.31

1.88

0.06

0.27

0.17

Follow up*Intervention

64.22

5

12.84

0.66

0.01

0.25

0.64

Residual

5224.34

271

19.27

    

Estimated marginal means (IOP dependent)

Follow up

n

Mean

Std. Error

95% Confidence interval

Baseline

50

24.78

0.62

23.54 to 26.01

1 Day

50

7.37

0.62

6.13 to 8.60

2 Weeks

50

9.48

0.62

8.24 to 10.71

1 Month

50

10.12

0.62

8.89 to 11.36

3 Months

50

10.98

0.62

9.74 to 12.21

6 Months

50

12.18

0.71

10.78 to 13.58

Follow up

Intervention

n

Mean ± SD

Std. Error

t-test (P)

95% Confidence interval

Baseline

Group A

25

23.52 ± 5.88

0.87

0.26

21.79 to 25.24

 

Group B

25

26.04 ± 8.76

0.89

24.27 to 27.80

1 Day

Group A

25

7.24 ± 3.47

0.87

0.76

5.51 to 8.96

 

Group B

25

7.50 ± 4.23

0.89

5.73 to 9.26

2 Weeks

Group A

25

8.88 ± 3.08

0.87

0.34

7.15 to 10.60

 

Group B

25

10.08 ± 5.48

0.89

8.31 to 11.84

1 Month

Group A

25

9.92 ± 3.25

0.87

0.49

8.19 to 11.64

 

Group B

25

10.33 ± 2.53

0.89

8.56 to 12.09

3 Months

Group A

25

11.20 ± 2.71

0.89

0.63

9.44 to 12.97

 

Group B

25

10.76 ± 2.78

0.87

9.03 to 12.48

6 Months

Group A

25

12.00 ± 3.13

0.63

0.89

10.01 to 13.98

 

Group B

25

12.36 ± 3.37

0.67

10.38 to 14.35

Pairwise comparisons (IOP dependent)

Mean difference

Std. Error

P a

95% CI a

Baseline

1 Day

17.41

0.88

< 0.0001

14.78 to 20.03

 

2 Weeks

15.29

0.88

< 0.0001

12.67 to 17.92

 

1 Month

14.65

0.88

< 0.0001

12.02 to 17.28

 

3 Months

13.79

0.88

< 0.0001

11.16 to 16.42

 

6 Months

12.59

0.94

< 0.0001

9.78 to 15.40

1 Day

Baseline

−17.41

0.88

< 0.0001

−20.03 to −14.78

 

2 Weeks

−2.11

0.88

0.27

−4.73 to 0.51

 

1 Month

−2.75

0.88

0.0314

−5.38 to −0.12

 

3 Months

−3.61

0.88

0.0009

−6.24 to −0.98

 

6 Months

−4.81

0.94

< 0.0001

−7.62 to −2.00

Pairwise comparisons (IOP dependent)

Mean difference

Std. Error

P a

95% CI a

2 Weeks

Baseline

−15.29

0.88

< 0.0001

− 17.92 to −12.67

 

1 Day

2.11

0.88

0.27

− 0.51 to 4.73

 

1 Month

−0.64

0.88

1.00

−3.27 to 1.98

 

3 Months

−1.50

0.88

1.00

−4.13 to 1.12

 

6 Months

−2.70

0.94

0.07

−5.51 to 0.10

1 Month

Baseline

−14.65

0.88

< 0.0001

−17.28 to −12.02

 

1 Day

2.75

0.88

0.0314

0.12 to 5.38

 

2 Weeks

0.64

0.88

1.00

−1.98 to 3.27

 

3 Months

−0.85

0.88

1.00

−3.48 to 1.77

 

6 Months

−2.05

0.94

0.46

−4.86 to 0.75

3 Months

Baseline

−13.79

0.88

< 0.0001

−16.42 to −11.16

 

1 Day

3.61

0.88

0.0009

0.98 to 6.24

 

2 Weeks

1.50

0.88

1.00

−1.12 to 4.13

 

1 Month

0.85

0.88

1.00

−1.77 to 3.48

 

6 Months

−1.20

0.94

1.00

−4.01 to 1.61

6 Months

Baseline

−12.59

0.94

< 0.0001

−15.40 to −9.78

 

1 Day

4.81

0.94

< 0.0001

2.00 to 7.62

 

2 Week

2.70

0.94

0.07

−0.10 to 5.51

 

1 Month

2.05

0.94

0.46

−0.75 to 4.86

 

3 Months

1.20

0.94

1.00

−1.61 to 4.01

  1. a Bonferroni corrected
  2. b Computed using alpha = 0.05
  3. Group A: Preserflo Microshunt with MMC 0.2 mg/ml
  4. Group B: Preserflo Microshunt with MMC 0.2 mg/ml and Ologen
  5. SD: standard deviation; DF: degrees of freedom; Eta: eta coefficient (An eta coefficient test is a method for determining the strength of association between a categorical variable)